CancerCancerCancer and Cell BiologyDisease AreaImmunotherapyLiver CancerLiver CancerLiver DiseaseLiver DiseaseNews & EventsResearchTumoursxOncofetal Ecosystem
New biomarker predicts liver cancer recurrence and immunotherapy response
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Disease Area, Immunotherapy, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Research, Tumours, xOncofetal EcosystemAnalysis of the environment that surrounds liver cancer tumours has revealed that patients with a high concentration of a certain cell type have early return of aggressive cancer but do…
awardsCancerCancerCancer EpigeneticsCentre for Diabetes ResearchDiabetesDiabetesFundingInspirationLiverLiver CancerLiver CancerLiver DiseaseLiver DiseaseNews & EventsTranslational Oncology
Perkins secures biobanking grants to answer important questions in future research
By Alicia Bienkowski | awards, Cancer, Cancer, Cancer Epigenetics, Centre for Diabetes Research, Diabetes, Diabetes, Funding, Inspiration, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Translational OncologyThe McGowan Government recently announced that the Harry Perkins Institute will receive two of the 16 grants totalling more than $1.5 million to support Western Australian biobanks. Congratulations to both…
awardsCancerCancerFundingLiverLiver CancerLiver CancerLiver DiseaseLiver DiseaseNews & EventsxOncofetal Ecosystem
NHMRC funding for DEFINER to identify “the right drug for the right patient” in liver cancer
By Alicia Bienkowski | awards, Cancer, Cancer, Funding, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, xOncofetal EcosystemThe Harry Perkins Institute's Oncofetal Ecosystem Laboratory, established early in 2021, has received its first NHMRC Ideas Grant in the most recent grants round. This collaborative project run by the…
